QUADRANT CAPITAL GROUP LLC - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 228 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$6,338
+58.4%
7,154
+216.3%
0.00%0.0%
Q3 2022$4,000
-20.0%
2,2620.0%0.00%0.0%
Q2 2022$5,000
-16.7%
2,262
-8.2%
0.00%0.0%
Q1 2022$6,000
-45.5%
2,464
+8.9%
0.00%0.0%
Q4 2021$11,000
-35.3%
2,2620.0%0.00%
-50.0%
Q3 2021$17,000
-22.7%
2,2620.0%0.00%
-33.3%
Q2 2021$22,000
+15.8%
2,2620.0%0.00%0.0%
Q1 2021$19,000
+26.7%
2,2620.0%0.00%0.0%
Q4 2020$15,000
+150.0%
2,262
+312.8%
0.00%
+200.0%
Q3 2020$6,0005480.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders